标普和纳斯达克内在价值 联系我们

Eargo, Inc. EAR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
29/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Eargo, Inc. (EAR) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 28/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
29/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
20/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
~
健康
67/100
Debt-to-Equity & liquidity
→ Health
护城河
21/100
→ Income
~
成长
58/100
→ Income
收入
10/100
→ Income

估值概览 — EAR

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.27
EV/EBITDA0.0
每股数据
EPS (TTM)$-39.68
每股账面价值$0.00
每股营收$9.39
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2017 $-2,230.32 $6.62M $-24.62M -371.8%
2018 $-2,993.71 $23.16M $-33.79M -145.9%
2019 $-3,469.23 $32.79M $-44.49M -135.7%
2020 $-76.10 $69.15M $-30.02M -43.4%
2021 $-81.11 $32.12M $-157.75M -491.1%
2022 $-39.68 $37.25M $-157.49M -422.8%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言